NCT00101764View on ClinicalTrials.gov

Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal Disorders

PHASE1CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

January 5, 2005

Study Completion Date

May 20, 2008

Conditions

Macular DegenerationRetinal Vein OcclusionDiabetic Retinopathy

Interventions

DRUG

Triamcinolone Acetonide

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors

lead

National Eye Institute (NEI)

NIH

NCT00101764 - Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal Disorders | Biotech Hunter | Biotech Hunter